| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 1.09e-17 | 63 | 37 | 10 | GO:0033120 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F | 4.55e-17 | 44 | 37 | 9 | GO:0048026 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F | 1.31e-16 | 49 | 37 | 9 | GO:0050685 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 1.94e-14 | 129 | 37 | 10 | GO:0048024 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 1.52e-13 | 158 | 37 | 10 | GO:0050684 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 2.29e-12 | 207 | 37 | 10 | GO:0043484 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 5.03e-10 | 358 | 37 | 10 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 5.03e-10 | 358 | 37 | 10 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 5.60e-10 | 362 | 37 | 10 | GO:0000375 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F | 6.18e-10 | 259 | 37 | 9 | GO:1903313 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 3.91e-09 | 443 | 37 | 10 | GO:1903311 |
| GeneOntologyBiologicalProcess | RNA splicing | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 1.29e-08 | 502 | 37 | 10 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA processing | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 3.11e-08 | 551 | 37 | 10 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 3.35e-06 | 917 | 37 | 10 | GO:0016071 |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | RBMY1D RBMY1B CIRBP RBMY1E AFDN HIF1A RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 4.80e-06 | 1446 | 37 | 12 | GO:0010628 |
| GeneOntologyBiologicalProcess | RNA processing | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 DDX18 RBMY1C RBMY1F | 4.24e-05 | 1500 | 37 | 11 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.61e-04 | 59 | 37 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | gonad development | 1.65e-04 | 292 | 37 | 5 | GO:0008406 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 1.79e-04 | 297 | 37 | 5 | GO:0045137 | |
| GeneOntologyBiologicalProcess | male gonad development | 2.43e-04 | 171 | 37 | 4 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 2.49e-04 | 172 | 37 | 4 | GO:0046546 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 3.83e-04 | 79 | 37 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | sex differentiation | 3.92e-04 | 352 | 37 | 5 | GO:0007548 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 4.17e-04 | 197 | 37 | 4 | GO:0002244 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 4.33e-04 | 199 | 37 | 4 | GO:0046661 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 5.68e-04 | 382 | 37 | 5 | GO:0009416 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 5.75e-04 | 383 | 37 | 5 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 6.10e-04 | 388 | 37 | 5 | GO:0061458 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.14e-03 | 115 | 37 | 3 | GO:1903312 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.15e-03 | 28 | 37 | 2 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.23e-03 | 29 | 37 | 2 | GO:0050686 | |
| GeneOntologyCellularComponent | spliceosomal complex | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F | 8.06e-11 | 215 | 36 | 9 | GO:0005681 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RBMY1D RBMY1B CIRBP RBMY1E HIF1A BRCA2 RBMXL1 SUN2 RBMX RBMY1A1 RBMY1C RBMY1F HMGXB4 | 2.30e-07 | 1377 | 36 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.42e-05 | 86 | 36 | 4 | GO:0001673 | |
| GeneOntologyCellularComponent | supraspliceosomal complex | 1.73e-05 | 4 | 36 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | germ cell nucleus | 4.17e-05 | 113 | 36 | 4 | GO:0043073 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBMX RBMY1A1 RBMY1C RBMY1F | 1.45e-04 | 1194 | 36 | 9 | GO:1990904 |
| Domain | RBM1CTR | 3.42e-19 | 8 | 35 | 7 | PF08081 | |
| Domain | RBM1CTR | 3.42e-19 | 8 | 35 | 7 | IPR012604 | |
| Domain | RRM | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 MATR3 RBMY1F | 5.19e-12 | 217 | 35 | 10 | SM00360 |
| Domain | RRM_dom | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 MATR3 RBMY1F | 8.12e-12 | 227 | 35 | 10 | IPR000504 |
| Domain | RRM | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 MATR3 RBMY1F | 9.25e-12 | 230 | 35 | 10 | PS50102 |
| Domain | Nucleotide-bd_a/b_plait | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 MATR3 RBMY1F | 2.88e-11 | 258 | 35 | 10 | IPR012677 |
| Domain | - | 5.02e-10 | 244 | 35 | 9 | 3.30.70.330 | |
| Domain | RRM_1 | 3.76e-09 | 208 | 35 | 8 | PF00076 | |
| Domain | RRM_dom_euk | 1.04e-05 | 23 | 35 | 3 | IPR003954 | |
| Domain | RRM_1 | 1.04e-05 | 23 | 35 | 3 | SM00361 | |
| Domain | Znf_C2H2_matrin | 2.23e-04 | 12 | 35 | 2 | IPR000690 | |
| Domain | ZF_MATRIN | 5.12e-04 | 18 | 35 | 2 | PS50171 | |
| Domain | ZnF_U1 | 1.34e-03 | 29 | 35 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.34e-03 | 29 | 35 | 2 | IPR003604 | |
| Domain | Helicase_C | 1.71e-02 | 107 | 35 | 2 | PF00271 | |
| Domain | HELICc | 1.71e-02 | 107 | 35 | 2 | SM00490 | |
| Domain | Helicase_C | 1.74e-02 | 108 | 35 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 1.77e-02 | 109 | 35 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.77e-02 | 109 | 35 | 2 | PS51192 | |
| Domain | DEXDc | 1.77e-02 | 109 | 35 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.80e-02 | 110 | 35 | 2 | IPR014001 | |
| Pathway | WP_MRNA_PROCESSING | 1.34e-06 | 451 | 27 | 8 | MM15946 | |
| Pubmed | 6.62e-18 | 7 | 37 | 6 | 8269511 | ||
| Pubmed | 8.70e-16 | 12 | 37 | 6 | 9598316 | ||
| Pubmed | 6.16e-15 | 6 | 37 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 2.16e-14 | 7 | 37 | 5 | 8875892 | |
| Pubmed | 1.32e-12 | 13 | 37 | 5 | 10749975 | ||
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 3.06e-12 | 15 | 37 | 5 | 14762062 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 5.41e-12 | 5 | 37 | 4 | 8817321 | |
| Pubmed | 5.41e-12 | 5 | 37 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 5.41e-12 | 5 | 37 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 5.41e-12 | 5 | 37 | 4 | 19737860 | |
| Pubmed | 1.62e-11 | 6 | 37 | 4 | 18239052 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 1.62e-11 | 6 | 37 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 1.62e-11 | 6 | 37 | 4 | 12356914 | |
| Pubmed | 1.62e-11 | 6 | 37 | 4 | 9499427 | ||
| Pubmed | 1.62e-11 | 6 | 37 | 4 | 15051956 | ||
| Pubmed | 3.78e-11 | 7 | 37 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 3.78e-11 | 7 | 37 | 4 | 10377282 | |
| Pubmed | 7.56e-11 | 8 | 37 | 4 | 7479793 | ||
| Pubmed | 2.27e-10 | 10 | 37 | 4 | 10601091 | ||
| Pubmed | 2.27e-10 | 10 | 37 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 5.33e-10 | 12 | 37 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 7.69e-10 | 13 | 37 | 4 | 23816659 | |
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 1.08e-09 | 14 | 37 | 4 | 14611631 | |
| Pubmed | RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene. | 1.11e-09 | 3 | 37 | 3 | 10391207 | |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 2.55e-09 | 17 | 37 | 4 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 3.28e-09 | 18 | 37 | 4 | 12023983 | |
| Pubmed | 1.59e-08 | 26 | 37 | 4 | 35920200 | ||
| Pubmed | 7.38e-08 | 347 | 37 | 7 | 16033648 | ||
| Pubmed | 1.32e-07 | 10 | 37 | 3 | 10332027 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 3.56e-07 | 55 | 37 | 4 | 19468303 | |
| Pubmed | 4.73e-07 | 59 | 37 | 4 | 11279525 | ||
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 1.10e-06 | 2 | 37 | 2 | 32473614 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 31866995 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.50e-06 | 1082 | 37 | 9 | 38697112 | |
| Pubmed | 3.22e-06 | 95 | 37 | 4 | 24029230 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 34458856 | ||
| Pubmed | RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet. | 3.30e-06 | 3 | 37 | 2 | 17188681 | |
| Pubmed | The candidate spermatogenesis gene RBMY has a homologue on the human X chromosome. | 3.30e-06 | 3 | 37 | 2 | 10391206 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 12165565 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 23409121 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 15983061 | ||
| Pubmed | The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. | 5.57e-06 | 241 | 37 | 5 | 12815422 | |
| Pubmed | 6.20e-06 | 112 | 37 | 4 | 28416769 | ||
| Pubmed | VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer. | 6.60e-06 | 4 | 37 | 2 | 23326384 | |
| Pubmed | SAFB1, an RBMX-binding protein, is a newly identified regulator of hepatic SREBP-1c gene. | 6.60e-06 | 4 | 37 | 2 | 19403048 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 22344029 | ||
| Pubmed | 8.91e-06 | 713 | 37 | 7 | 29802200 | ||
| Pubmed | 2.12e-05 | 153 | 37 | 4 | 28225217 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 2.96e-05 | 56 | 37 | 3 | 26919559 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.00e-05 | 861 | 37 | 7 | 36931259 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 3.16e-05 | 1203 | 37 | 8 | 29180619 | |
| Pubmed | A mechanism for the suppression of homologous recombination in G1 cells. | 3.95e-05 | 9 | 37 | 2 | 26649820 | |
| Pubmed | 4.93e-05 | 10 | 37 | 2 | 32814086 | ||
| Pubmed | Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy. | 4.93e-05 | 10 | 37 | 2 | 32615085 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 5.30e-05 | 1294 | 37 | 8 | 30804502 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 5.73e-05 | 954 | 37 | 7 | 36373674 | |
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 6.02e-05 | 11 | 37 | 2 | 14729963 | |
| Pubmed | 8.61e-05 | 80 | 37 | 3 | 35803934 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 8.88e-05 | 430 | 37 | 5 | 38172120 | |
| Pubmed | 8.93e-05 | 81 | 37 | 3 | 26990986 | ||
| Pubmed | 9.05e-05 | 222 | 37 | 4 | 37071664 | ||
| Pubmed | 9.68e-05 | 711 | 37 | 6 | 33022573 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.07e-04 | 232 | 37 | 4 | 25515538 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.18e-04 | 457 | 37 | 5 | 32344865 | |
| Pubmed | 1.46e-04 | 1497 | 37 | 8 | 31527615 | ||
| Pubmed | SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice. | 1.48e-04 | 17 | 37 | 2 | 22318228 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 1.72e-04 | 101 | 37 | 3 | 24613305 | |
| Pubmed | Next-generation sequencing to generate interactome datasets. | 1.80e-04 | 1147 | 37 | 7 | 21516116 | |
| Pubmed | 2.15e-04 | 109 | 37 | 3 | 29511296 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 3.15e-04 | 1257 | 37 | 7 | 36526897 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 3.58e-04 | 1284 | 37 | 7 | 17353931 | |
| Pubmed | 4.09e-04 | 28 | 37 | 2 | 22178446 | ||
| Pubmed | 4.30e-04 | 138 | 37 | 3 | 30320910 | ||
| Pubmed | 4.39e-04 | 29 | 37 | 2 | 16966370 | ||
| Pubmed | 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. | 4.70e-04 | 30 | 37 | 2 | 16306228 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 5.49e-04 | 150 | 37 | 3 | 28242625 | |
| Pubmed | 5.69e-04 | 33 | 37 | 2 | 30037926 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 5.70e-04 | 989 | 37 | 6 | 36424410 | |
| Pubmed | 6.05e-04 | 652 | 37 | 5 | 31180492 | ||
| Pubmed | 6.18e-04 | 655 | 37 | 5 | 35819319 | ||
| Pubmed | 6.50e-04 | 159 | 37 | 3 | 22751105 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 6.84e-04 | 1024 | 37 | 6 | 24711643 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 6.84e-04 | 670 | 37 | 5 | 22990118 | |
| Pubmed | 7.76e-04 | 689 | 37 | 5 | 36543142 | ||
| Pubmed | 8.71e-04 | 707 | 37 | 5 | 19738201 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 9.31e-04 | 180 | 37 | 3 | 35198878 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.92e-04 | 184 | 37 | 3 | 32908313 | |
| Pubmed | 1.01e-03 | 731 | 37 | 5 | 29298432 | ||
| Pubmed | 1.02e-03 | 421 | 37 | 4 | 34650049 | ||
| Interaction | RBMY1F interactions | 5.70e-09 | 36 | 37 | 5 | int:RBMY1F | |
| Interaction | RBMY1E interactions | 2.28e-08 | 4 | 37 | 3 | int:RBMY1E | |
| Interaction | RBMY1J interactions | 2.21e-07 | 29 | 37 | 4 | int:RBMY1J | |
| Interaction | RBMY1A1 interactions | 3.33e-07 | 32 | 37 | 4 | int:RBMY1A1 | |
| Interaction | RBMX interactions | 1.52e-06 | 461 | 37 | 8 | int:RBMX | |
| Interaction | MTF1 interactions | 2.91e-06 | 123 | 37 | 5 | int:MTF1 | |
| Interaction | PCDHB14 interactions | 8.56e-06 | 22 | 37 | 3 | int:PCDHB14 | |
| Interaction | MECP2 interactions | CIRBP NKTR SIK3 GPATCH8 RBMXL1 SUN2 RBMX MATR3 DDX18 RBAK HMGXB4 | 1.26e-05 | 1287 | 37 | 11 | int:MECP2 |
| Interaction | APOBEC3C interactions | 2.23e-05 | 187 | 37 | 5 | int:APOBEC3C | |
| Interaction | SRSF3 interactions | 3.94e-05 | 522 | 37 | 7 | int:SRSF3 | |
| Interaction | CLK3 interactions | 4.86e-05 | 220 | 37 | 5 | int:CLK3 | |
| Interaction | YWHAB interactions | 6.92e-05 | 1014 | 37 | 9 | int:YWHAB | |
| Interaction | RASD1 interactions | 8.19e-05 | 46 | 37 | 3 | int:RASD1 | |
| Interaction | PRR3 interactions | 8.24e-05 | 246 | 37 | 5 | int:PRR3 | |
| Interaction | LINC01232 interactions | 1.17e-04 | 9 | 37 | 2 | int:LINC01232 | |
| Interaction | LNX1 interactions | 1.33e-04 | 634 | 37 | 7 | int:LNX1 | |
| Interaction | SNRNP40 interactions | 1.37e-04 | 637 | 37 | 7 | int:SNRNP40 | |
| Interaction | ZNF330 interactions | 1.48e-04 | 446 | 37 | 6 | int:ZNF330 | |
| Interaction | DHX8 interactions | 1.84e-04 | 292 | 37 | 5 | int:DHX8 | |
| Interaction | FBXW11 interactions | 2.03e-04 | 473 | 37 | 6 | int:FBXW11 | |
| Interaction | USP21 interactions | 2.11e-04 | 161 | 37 | 4 | int:USP21 | |
| Interaction | DDX23 interactions | 2.20e-04 | 480 | 37 | 6 | int:DDX23 | |
| Interaction | RBM3 interactions | 2.21e-04 | 163 | 37 | 4 | int:RBM3 | |
| Interaction | SNRPA interactions | 2.25e-04 | 482 | 37 | 6 | int:SNRPA | |
| Interaction | CIRBP interactions | 2.26e-04 | 164 | 37 | 4 | int:CIRBP | |
| Interaction | SFN interactions | 2.29e-04 | 692 | 37 | 7 | int:SFN | |
| Interaction | CHD4 interactions | 2.47e-04 | 938 | 37 | 8 | int:CHD4 | |
| Interaction | HIF1AN interactions | 2.69e-04 | 317 | 37 | 5 | int:HIF1AN | |
| Interaction | ZNF707 interactions | 4.09e-04 | 79 | 37 | 3 | int:ZNF707 | |
| Interaction | CLK2 interactions | 4.37e-04 | 195 | 37 | 4 | int:CLK2 | |
| Cytoband | Yq11.223 | 1.27e-08 | 93 | 37 | 5 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 5.04e-06 | 311 | 37 | 5 | chrYq11 | |
| Cytoband | 11q23.3 | 1.83e-03 | 78 | 37 | 2 | 11q23.3 | |
| Cytoband | 22q13.1 | 2.16e-03 | 85 | 37 | 2 | 22q13.1 | |
| GeneFamily | RNA binding motif containing | RBMY1D RBMY1B CIRBP RBMY1E RBMXL1 RBM20 RBMX RBMY1A1 RBMY1C RBMY1F | 7.08e-14 | 213 | 24 | 10 | 725 |
| GeneFamily | PDZ domain containing | 1.72e-02 | 152 | 24 | 2 | 1220 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.19e-07 | 33 | 36 | 4 | MM701 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 4.29e-07 | 45 | 36 | 4 | MM763 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.68e-05 | 856 | 36 | 8 | M4500 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 1.48e-04 | 196 | 36 | 4 | M5381 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP | 1.54e-04 | 198 | 36 | 4 | M5289 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP | 1.54e-04 | 198 | 36 | 4 | M5299 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | 1.59e-04 | 873 | 36 | 7 | M16009 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 1.60e-04 | 200 | 36 | 4 | M9411 | |
| Coexpression | GSE14308_TH2_VS_TH17_UP | 1.60e-04 | 200 | 36 | 4 | M3361 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 1.60e-04 | 200 | 36 | 4 | M9211 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 189 | 34 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.27e-05 | 189 | 34 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-05 | 196 | 34 | 4 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.94e-04 | 148 | 34 | 3 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.86e-04 | 169 | 34 | 3 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-04 | 170 | 34 | 3 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.96e-04 | 171 | 34 | 3 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 176 | 34 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.44e-04 | 180 | 34 | 3 | 05f14cd367021891166825a8aac171227e2bcd97 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 180 | 34 | 3 | a0faed4cf23f6d5e6e8f6b0284cea8a5bd0680a0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-04 | 182 | 34 | 3 | c3eafdc11858566aa7692b2f5dbe72ac01fb769a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-04 | 183 | 34 | 3 | 4bd6883daf2dbe8c1b49b776b48d41f9890d1cb4 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-04 | 183 | 34 | 3 | cff3197e9ff401362501db2317c86adc6d24b595 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-04 | 183 | 34 | 3 | f803dd2881ceaed6327e21a1a51bc3d3ccf4b5f8 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-04 | 184 | 34 | 3 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 184 | 34 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgM_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.73e-04 | 185 | 34 | 3 | 26ea60b6392410fab048f2e406a9860a018429cc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.91e-04 | 188 | 34 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.91e-04 | 188 | 34 | 3 | 47126c371a242c937499fd278a74a882df8f759c | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 3.97e-04 | 189 | 34 | 3 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 189 | 34 | 3 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | IPF-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.97e-04 | 189 | 34 | 3 | ad7bb3a7de8e48c145e4382f90d30bb2159c2b76 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.97e-04 | 189 | 34 | 3 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 190 | 34 | 3 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 190 | 34 | 3 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 4.03e-04 | 190 | 34 | 3 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 4.03e-04 | 190 | 34 | 3 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.09e-04 | 191 | 34 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 4.15e-04 | 192 | 34 | 3 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.15e-04 | 192 | 34 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.22e-04 | 193 | 34 | 3 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.22e-04 | 193 | 34 | 3 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 34 | 3 | 55eab7d2574e9cc2ed8f08e0a7ca7cbf90fb5818 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 34 | 3 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 194 | 34 | 3 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 194 | 34 | 3 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 194 | 34 | 3 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 194 | 34 | 3 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 4.28e-04 | 194 | 34 | 3 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.28e-04 | 194 | 34 | 3 | 28571cf24b8a1d0ffb716167b977d420868cc874 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-04 | 196 | 34 | 3 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.48e-04 | 197 | 34 | 3 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.48e-04 | 197 | 34 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-04 | 197 | 34 | 3 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 197 | 34 | 3 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | CV-Moderate|CV / Virus stimulation, Condition and Cluster | 4.48e-04 | 197 | 34 | 3 | 8747a57ded96175a8365f066101ce2af80c8081d | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.54e-04 | 198 | 34 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.54e-04 | 198 | 34 | 3 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-04 | 198 | 34 | 3 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-04 | 198 | 34 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.54e-04 | 198 | 34 | 3 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 4.61e-04 | 199 | 34 | 3 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.61e-04 | 199 | 34 | 3 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 4.61e-04 | 199 | 34 | 3 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 4.68e-04 | 200 | 34 | 3 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.68e-04 | 200 | 34 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | azafagomine | 2.92e-08 | 57 | 36 | 5 | CID011957435 | |
| Drug | hydantoin-5-propionic acid | 3.09e-08 | 21 | 36 | 4 | CID000000782 | |
| Drug | AZFd | 4.56e-08 | 23 | 36 | 4 | CID000196489 | |
| Drug | Vistar | 2.99e-07 | 36 | 36 | 4 | CID000040896 | |
| Drug | 2-chlorodideoxyadenosine | 6.22e-07 | 43 | 36 | 4 | CID000072194 | |
| Drug | PKI166 | 9.74e-07 | 48 | 36 | 4 | CID006918403 | |
| Drug | HgCl | 1.06e-06 | 49 | 36 | 4 | CID000024182 | |
| Drug | thioglycolate | 3.76e-06 | 67 | 36 | 4 | CID000001133 | |
| Drug | SU6668 | 4.48e-06 | 70 | 36 | 4 | CID000206042 | |
| Drug | p11-13 | 5.91e-06 | 75 | 36 | 4 | CID000015759 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.32e-06 | 177 | 36 | 5 | 985_DN | |
| Drug | sodium azide | 9.73e-06 | 85 | 36 | 4 | CID000033557 | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 9.78e-06 | 183 | 36 | 5 | 7062_DN | |
| Drug | bipy | 1.64e-05 | 97 | 36 | 4 | CID000001474 | |
| Drug | 2-oyl | 2.25e-05 | 105 | 36 | 4 | CID000657137 | |
| Drug | carbonyl sulfide | 3.32e-05 | 116 | 36 | 4 | CID000010039 | |
| Drug | crinamine | 5.08e-05 | 7 | 36 | 2 | CID000073620 | |
| Drug | p-tolualdehyde | 8.69e-05 | 9 | 36 | 2 | CID000007725 | |
| Drug | oligoadenylate | 1.08e-04 | 157 | 36 | 4 | CID000107918 | |
| Drug | butin | 1.32e-04 | 11 | 36 | 2 | CID000092775 | |
| Disease | skin melanoma (is_implicated_in) | 9.02e-05 | 14 | 30 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | prostate cancer (is_implicated_in) | 2.28e-04 | 117 | 30 | 3 | DOID:10283 (is_implicated_in) | |
| Disease | cutaneous squamous cell carcinoma | 5.17e-04 | 33 | 30 | 2 | EFO_1001927 | |
| Disease | melanoma (is_implicated_in) | 5.49e-04 | 34 | 30 | 2 | DOID:1909 (is_implicated_in) | |
| Disease | Bipolar Disorder | 1.32e-03 | 477 | 30 | 4 | C0005586 | |
| Disease | Malignant neoplasm of skin | 1.65e-03 | 59 | 30 | 2 | C0007114 | |
| Disease | Skin Neoplasms | 1.65e-03 | 59 | 30 | 2 | C0037286 | |
| Disease | prostate carcinoma | 1.89e-03 | 891 | 30 | 5 | EFO_0001663 | |
| Disease | Major Depressive Disorder | 1.90e-03 | 243 | 30 | 3 | C1269683 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YNYHTYEDGSDSRDK | 401 | P55196 | |
| YDGYDRFEFSHSYSK | 146 | O94923 | |
| SSEYTHHKSSRDYRY | 1646 | O14646 | |
| AYRDYGHSRRDESYS | 276 | P0DJD3 | |
| AYRDYGHSRRDESYS | 276 | A6NDE4 | |
| AYRDYGHSRRDESYS | 276 | P0DJD4 | |
| AYRDYGHSRRDESYS | 276 | P0C7P1 | |
| AYRDYGHSRRDESYS | 276 | A6NEQ0 | |
| AYRDYGHSRRDESYS | 276 | Q15415 | |
| PHSVSSYKSREDGYY | 746 | Q5T481 | |
| DDGYSTKDSYSSRDY | 211 | P38159 | |
| YTYRDYGHSSSRDDY | 241 | P38159 | |
| DYSDHPSGGSYRDSY | 271 | P38159 | |
| DYDHGSRSQESGYYD | 201 | P43243 | |
| TGTADASQSDYSKYY | 166 | Q99456 | |
| YEYYHALDSDHLTKT | 276 | Q16665 | |
| DKLRHDGYRSSQYYS | 121 | Q5SYE7 | |
| QRSYSDDSYSDYSDR | 886 | Q9UKJ3 | |
| RKHSSDDYYYGDISS | 76 | Q9UGU5 | |
| EAYKSYIRAYDSHSL | 581 | Q9NVP1 | |
| EKSYYESHLGSSYIT | 306 | Q9NZC3 | |
| YHSDEVYNDSGYLSK | 1751 | P51587 | |
| YDSYSESSGYKNHDR | 1526 | Q5VT06 | |
| HFHDYKSDVTSYDYD | 331 | Q8IW92 | |
| EYEHGYVSDEHTYSR | 91 | Q3B7T3 | |
| SRHFEDTSYGYKDFS | 326 | Q9Y6P5 | |
| DDGYSTKDSYSSRDY | 211 | Q96E39 | |
| YTYRDYGHSSSRDDY | 241 | Q96E39 | |
| DYSDHPSGGSYRDSY | 271 | Q96E39 | |
| SGYHYLRSTVSDRYK | 346 | P48775 | |
| SSYDPHSRSRSYTYD | 1391 | P30414 | |
| DSTGTHSLYTTYKDY | 666 | O43166 | |
| SLRSDAYDHYSAIYS | 366 | Q9Y2K2 | |
| SGGSYRDSYDSYATH | 156 | Q14011 | |
| SSGYSSEDDYVGYSD | 131 | Q9UH99 | |
| LSYYTEHYRSHSEEK | 551 | Q9NYW8 | |
| SSKDLGYDYSYLQDS | 441 | P14679 | |
| GDHVYTYSYDAKRED | 151 | O95427 | |
| SHRYAETHGCTYDYK | 691 | Q86XD8 | |
| TYDYKSAGRRYLHEA | 701 | Q86XD8 | |
| YTESARYTDAHYAKS | 11 | O75604 | |
| SFEDRYDYYSKAEAH | 221 | Q6P5S2 | |
| ADYATLYYREHSRAG | 81 | O15049 |